GC Rieber VivoMega to make significant investment in facility expansion

Photo © iStockphoto.com/ evemilla

GC Rieber VivoMega (Norway) has announced a five-year $75 million investment plan to build a new facility at its manufacturing campus, with an anticipated completion date of early 2024. The new facility will enable the company to more than double the output of its high-end triglyceride form of omega-3s EPA and DHA.

“This investment is part of GC Rieber VivoMega’s continual commitment to develop the needed facilities for the increased capacity and production of our industry leading omega-3 oils,” said Jan Roger Bjerkestrand, managing director of GC Rieber VivoMega, in a press release. “To minimize our eco-footprint, we will be leveraging much of the existing infrastructure, including docks, tanks, laboratories, and energy to provide the same high-quality product that our customers are asking for.”

By the summer of 2022, GC Rieber VivoMega will complete the construction of a 32,000-metric ton tank park and updated technology platform in their existing manufacturing plants. The tank park enables the company to adjust to current supply chain challenges and is a key strategic asset to supporting the new expansion. Therefore, the new facility is also being designed with added flexibility to support future strategic growth areas in omega-3 high-end concentrates.